###
中国临床研究英文版:2023,36(4):610-614
本文二维码信息
码上扫一扫!
不同Bristol粪便分型肠镜前肠道准备方案的优选
(安徽医科大学第一附属医院 安徽省公共卫生临床中心,安徽 合肥 230012)
Optimization of pre-colonoscopy intestinal preparation schemes based on different Bristol stool form typing
(The First Affiliated Hospital of Anhui Medical University, Anhui Public Health Clinical Center, Hefei, Anhui 230012, China)
摘要
本文已被:浏览 478次   下载 1178
Received:December 05, 2022   Published Online:April 20, 2023
中文摘要: 目的 探讨根据Bristol粪便分型图(BSFS)分型不同优化的肠镜前肠道准备方案的临床效果。 方法 分析2020年5月至2021年1月在安徽医科大学第一附属医院北区接受结肠镜检查的150例患者的临床资料,根据Bristol粪便分型及用药方案不同分为A(Bristol 1~4型)、B(Bristol 1~4型)、C(Bristol 5~7型)三组,每组50例,三组均服用1.5 L聚乙二醇电解质口服溶液,A组检查前1天加用普芦卡必利2mg。比较三组Boston肠道准备评估量表(BBPS)、全结肠道准备充分率、息肉检出率、肠道准备不良反应和患者接受率。 结果 A组的BBPS总分明显高于B组[(6.50±0.79)分vs(5.58±0.81)分,P<0.05],A组与C组比较差异无统计学意义[(6.50±0.79)vs(6.32±0.79)分,P>0.05];肠道准备充分率A组和C组(92.00%,80.00%)明显高于B组(58.00%)(P<0.05);三组患者的肠道准备接受率、息肉检出率和不良反应比较,差异均无统计学意义(P>0.05)。 结论 按照BSFS指导的肠道准备简单有效,减量的1.5L方案接受率高且不良反应少,加用普芦卡必利对Bristol 1~4型患者的肠道准备效果有明显提高。
Abstract:Objective To explore the clinical effects of pre-colonoscopic intestinal preparation schemes optimized according to Bristol stool form scale(BSFS) typing. Methods The clinical data of 150 patients received colonoscopy in the First Affiliated Hospital of Anhui Medical University from May 2020 to January 2021 were retrospectively analyzed. According to the Bristol stool form type and medication regimen, the patients were divided into three groups(n=50, each): group A (Bristol 1~4), group B (Bristol 1~4) and group C (Bristol 5~7). 1.5L polyethylene glycol and electrolyte oral solution(PEG-ELS) were used in three groups,and prucalopride 2 mg was added one day before examination in group A. Boston bowel preparation scale(BBPS), total bowel preparation rate, polyp detection rate(PDR), adverse reactions rate and patients acceptance rate were compared among three groups. Results The total BBPS score in group A was significantly higher than that in group B(6.50±0.79 vs 5.58±0.81, P<0.05) and was similar to that in group C(6.50±0.79 vs 6.32±0.79, P>0.05). The successful rates of intestinal preparation in group A(92.00%)and group C(80.00%) were significantly higher than that in group B(58.00%, P<0.05). There were no significant differences in patients acceptance rate,PDR and adverse reactions among three groups(P >0.05). Conclusion Intestinal preparation according to BSFS is simple and effective. The reduced amount of PEG-ELS(1.5L) has a high acceptance rate and fewer adverse reactions, which can significantly improve the effect of intestinal preparation in combination with prucalopride for the patients of BSFS score 1-4.
文章编号:     中图分类号:R574    文献标志码:B
基金项目:安徽医科大学临床医学学科建设项目基金(2020lcxk033)
引用文本:


Scan with WeChat

Scan with WeChat